Print Save or Share

User Reviews for Kristalose

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Kristalose.

Condition	Reviews	Compare	Avg. Ratings
Constipation, Acute	0 reviews	32 medications		3.0
Constipation, Chronic	0 reviews	27 medications	Not rated - Be the first
Hepatic Encephalopathy	0 reviews	16 medications	Not rated - Be the first

Reviews for Kristalose

There are no reviews - Be the first

See also...

Sign In or Register

Forgot password?

Related Kristalose Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category No proven risk in humans

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

Get Updates by Email

Email me about Kristalose:

Related News and Articles

Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide 8 February 2012
Feb 8, 2012 - Ironwood Pharmaceuticals, Inc. announced that it was informed this evening that the U.S. Food and Drug Administration (FDA) will not schedule...
Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation 27 October 2011
Data to be presented at ACG 2011 Annual Scientific Meeting CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Oct 27, 2011 - Ironwood Pharmaceuticals, Inc....
Synergy Pharmaceuticals Presentations at 2011 American College of Gastroenterology Annual Scientific Meeting 27 October 2011
Oct 27, 2011 - Synergy Pharmaceuticals, Inc. (OTC QB:SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today...
Linaclotide provides long term relief from the symptoms of irritable bowel syndrome with constipation 27 October 2011
Full results from two Phase III linaclotide trials involving over 1,600 patients with irritable bowel syndrome with constipation (IBS-C) presented at the...
Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review 24 October 2011
Oct 24, 2011 - Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted...

Related Questions & Answers

More Kristalose questions

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

Copyright © 2000-2012 Drugs.com. All rights reserved.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

(web6)